Related Experiment Video
Updated: Apr 18, 2026

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
11.1K
A power series beta Weibull regression model for predicting breast carcinoma
Edwin M M Ortega1, Gauss M Cordeiro, Ana K Campelo
1Department of Exact Sciences, University of São Paulo, Piracicaba, Brazil.
Statistics in Medicine
|January 27, 2015
Summary
This study introduces a novel survival regression model to improve breast carcinoma survival predictions after mastectomy. The new model offers more accurate mortality predictions by considering various prognostic factors and competing risks.
Area of Science:
- Biostatistics
- Oncology
- Medical Statistics
Background:
- Current postmastectomy survival rates lack individual patient accuracy.
- Pathologic factors like tumor size and lymph node status significantly impact prognosis.
- Existing models may not fully capture the complexities of breast carcinoma survival.
Purpose of the Study:
- To develop a new cure rate survival regression model for predicting breast carcinoma survival in women post-mastectomy.
- To improve the accuracy of individual patient survival predictions beyond traditional statistical methods.
- To incorporate competing risks and specific distributional assumptions for enhanced predictive power.
Main Methods:
- Proposed a novel compounding regression model for cure rate survival analysis.
- Assumed power series distribution for competing causes and beta Weibull for metastasis time.
- Employed maximum likelihood estimation for model parameter estimation.
- Conducted simulations to evaluate model performance under various conditions.
- Derived matrices for assessing local influences on parameter estimates.
Main Results:
- The proposed model offers a flexible framework, encompassing several existing cure rate models.
- Simulations demonstrated the model's robustness across different parameter settings, sample sizes, and censoring levels.
- Local influence assessment methods were developed to understand model sensitivity.
- The model's potential for accurate breast carcinoma mortality prediction was validated using real patient data.
Conclusions:
- The new regression model provides a more accurate approach to predicting breast carcinoma survival post-mastectomy.
- The model's flexibility and incorporation of key prognostic factors enhance its clinical applicability.
- This statistical advancement holds promise for personalized patient management and treatment strategies.
Related Concept Videos
Parametric Survival Analysis: Weibull and Exponential Methods
1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Cancer Survival Analysis
855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Comparing the Survival Analysis of Two or More Groups
727
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
727
Kaplan-Meier Approach
769
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
769

